Increased 2025 guidance with expected net revenues of $756.0 million to $776.0 million and adjusted non-GAAP EBITDA of $190.0 ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $22.38, a high estimate of $25.00, ...

FY Revenue of $291.3 million, up 9% over 2023; Delivered FY 2024 net income of $12.5 million or 4% margin; FY adjusted EBITDA increased 23% over 2023 and was $92.3 million or 32% margin; Revenue ...

In fact, it’s estimated that accounting errors and manual financial reporting cost U.S. businesses around $7.8 billion a year. And those mistakes, whether seemingly small or glaringly obvious, can ...

Organogenesis ( ORGO -5.54%) Q4 2024 Earnings Call Feb 27, 2025, 5:00 p.m. ET ...

Data suggests that pursuing higher education can at least boost the net earnings of individuals of color. Black Americans ...

While recent deadly crashes in Kazakhstan, South Korea and the United States and the non-fatal flip of a crash-landed jet in ...

Intermap’s CEO Patrick A. Blott, CFO Jennifer Bakken and COO Jack Schneider will host a live webinar on Thursday, March 27, 2025, at 5:00 pm ET to review the results, provide Company updates and ...

Cytek will host a conference call to discuss its fourth quarter and year end 2024 financial results on Thursday, February 27, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A webcast of the ...

Seer will host a conference call to discuss the fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 at 1:30 pm Pacific Time / 4:30 pm Eastern Time. A webcast of the ...

Analysts have set 12-month price targets for ACADIA Pharmaceuticals, revealing an average target of $25.0, a high estimate of $28.00, and a low estimate of $20.00. A 2.91% drop is evident in the ...

Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) ("Ayurcann" or the "Company") is excited to announce record-breaking financial results for the three ...